Search Results 1191-1200 of 19945 for Hepatitis b

  1. Teplizumab-mzwv (intravenous route) - Side effects & uses - Mayo Clinic

    Haemophilus B Vaccine; Hepatitis A Vaccine, Inactivated; Hepatitis B Vaccine; Human Papillomavirus Vaccine; Influenza Virus Vaccine; Influenza Virus Vaccine ...

  2. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

    ... hepatitis B (HBV), or hepatitis C virus (HCV): a. Patients with HIV are excluded. a.b. Patients who are hepatitis B surface antigen positive are eligible if ...

  3. A Study to Evaluate the Long-Term Effectives on ALS Disease Progression of BIIB067 - Mayo Clinic

    Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or hepatitis B core antibody [HBcAb]). Participants with ...

  4. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    Ilyas, M.B.B.S.. Transplant Hepatologist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, ...

  5. A Study of DFRF4539A in Patients with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Positive for hepatitis B, hepatitis C or HIV infection; Pregnant or lactating ... B. Contact information: Cancer Center Clinical Trials Referral Office.

  6. TD-1473 for Active Ulcerative Colitis (UC) - Mayo Clinic

    ... hepatitis B surface antibody or detectable serum hepatitis B DNA. Has clinically significant abnormalities in laboratory evaluations; Participated in another ...

  7. Deucravacitinib (oral route) - Side effects & dosage - Mayo Clinic

    Liver disease (eg, hepatitis B or C) or; Tuberculosis, history of—Use with caution. May make these conditions worse. Infection, active or; Liver disease ...

  8. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    ... B Acute Lymphoblastic Leukemia ... Active viral or protozoal infection requiring IV treatment. Patients with known human immunodeficiency virus (HIV), hepatitis B ...

  9. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Evidence of chronic active Hepatitis B (HBV) infection as evidenced by a detectable hepatitis B surface antigen (HBsAg) (not including subjects with prior ...

  10. Stage 4 (metastatic) colon cancer - Doctors and departments - Mayo Clinic

    Transplant Hepatologist. Rochester, MN. Areas of focus: Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, Hepatocellular carcinoma, ...